# Taking GLP-1 Medications Like Ozempic? Watch for Heat-Related Risks
Parents and caregivers managing weight or diabetes with GLP-1 receptor agonists such as Ozempic, Wegovy, Mounjaro, or Zepbound need to take extra precautions during hot weather. These popular medications carry heightened risks during summer months, according to health experts.
GLP-1 drugs work by slowing gastric emptying and reducing appetite. This mechanism creates a double threat in heat. First, these medications reduce thirst signals in the brain, making dehydration more likely when temperatures climb. Second, they lower overall fluid intake, leaving bodies with less water to regulate temperature through perspiration.
Heat-related illness becomes a genuine concern. Dehydration accelerates when taking GLP-1s, increasing risks for heat exhaustion and heat stroke. Both conditions develop faster and more severely in people on these medications.
Dr. experts recommend several protective steps. Drink water consistently throughout the day, even if you don't feel thirsty. Set phone reminders for hydration breaks. Wear light-colored, breathable clothing. Limit time outdoors during peak heat hours between 10 a.m. and 4 p.m. Monitor urine color as a hydration marker; pale yellow indicates adequate water intake.
Watch for warning signs: excessive fatigue, dizziness, rapid heartbeat, confusion, or cessation of sweating. These signal heat illness and require immediate medical attention.
Parents of teens or young adults using GLP-1s for weight management should have explicit conversations about heat safety. Remind them that thirst isn't a reliable guide while on these medications. Pack water bottles for outdoor activities. Check in frequently during hot days.
Heat sensitivity with GLP-1s isn't permanent. It